B 类人格障碍对药物治疗社区治疗结果的影响：一项基于真实世界数据的研究
Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data.
作者信息
Dacosta-Sánchez Daniel, Díaz-Batanero Carmen, Fernandez-Calderon Fermin, Lozano Óscar M
机构信息
Department of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain.
Research Center for Natural Resources, Health and Environment, University of Huelva, 21071 Huelva, Spain.
出版信息
J Clin Med. 2021 Jun 10;10(12):2572. doi: 10.3390/jcm10122572.
BACKGROUND
The impact of dual pathology on treatment outcomes is unclear, with the literature reporting both favorable and unfavorable evidence. The main aim of this study was to determine how dual pathology affects treatment outcomes using real world data obtained from inpatients that began treatment in therapeutic communities.
METHOD
The data of 2458 inpatients were used. Clinical information was obtained from electronic medical records. Reliability of diagnosis was checked and revealed a mean kappa value of 0.88.
RESULTS
Of the sample, 41.8% were discharged after achieving the therapeutic objectives. Patients diagnosed with Cluster B personality disorders were found to have a higher risk of dropping out of treatment (HR = 1.320; z = 2.61; = 0.009).
CONCLUSIONS
Personality traits exhibited by Cluster B patients can interfere with treatment in therapeutic communities. There is a need to develop specific interventions for these inpatient groups, which could be implemented in therapeutic communities.
背景
双重病理对治疗结果的影响尚不清楚，文献报道了有利和不利的证据。本研究的主要目的是利用从在治疗社区开始治疗的住院患者中获得的真实世界数据，确定双重病理如何影响治疗结果。
方法
使用了2458名住院患者的数据。临床信息从电子病历中获取。检查了诊断的可靠性，发现平均kappa值为0.88。
结果
在样本中，41.8%的患者在实现治疗目标后出院。被诊断为B类人格障碍的患者退出治疗的风险更高（HR = 1.320；z = 2.61；P = 0.009）。
结论
B类患者表现出的人格特质会干扰治疗社区中的治疗。需要为这些住院患者群体制定具体的干预措施，这些措施可在治疗社区中实施。
Zotero 插件